enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Medicare announces lower prices on 10 common, high-cost drugs

   www.aol.com/news/first-time-medicare-cuts-prices...

   Here are the negotiated prices for the drugs, based on a 30-day supply: Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer: $231 negotiated price, down from $521 list price. Xarelto, a ...

3. Biden administration says Medicare negotiated price discounts ...

   www.aol.com/biden-administration-says-medicare...

   The list price of Merck's diabetes drug Januvia will be slashed to $113 for a 30-day supply from $527 as of 2023. Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer, will cost $231 for ...

4. Biden admin announces results of historic Medicare drug price ...

   www.aol.com/medicare-enrollees-save-billions...

   Eliquis: 56%. Entresto: 53%. Imbruvica: 38%. ... The senior may be on the hook for $3,400 for a 30-day supply today but would pay $1,100 after the negotiated price takes effect. (The actual ...

5. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [6][7][8] It is used an alternative to warfarin to prevent blood clots following hip or knee replacement and in those with a ...

6. Factbox-Top Medicare drugs headed for price cuts - AOL

   www.aol.com/news/factbox-top-medicare-drugs...

   Jardiance. Boehringer Ingelheim and Eli Lilly's Jardiance is used to treat type-2 diabetes, heart failure and chronic kidney disease. It cost Medicare $7 billion for 1.6 million patients in the ...

7. Priority review - Wikipedia

   en.wikipedia.org/wiki/Priority_review

   Priority review is a program of the United States Food and Drug Administration (FDA) to expedite the review process for drugs that are expected to have a particularly great impact on the treatment of a disease. The priority review voucher program is a program that grants a voucher for priority review to a drug developer as an incentive to ...

8. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Discovery and development of direct Xa inhibitors. Four drugs from the class of direct Xa inhibitors are marketed worldwide. Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [ 1] The second one was apixaban (Eliquis), approved in Europe in 2011 [ 2] and in the United ...

9. Medicare Price Cuts for 10 Common Prescription Drugs: What to ...

   www.aol.com/lifestyle/medicare-price-cuts-10...

   Eliquis (prevention and treatment of blood clots): 56%. Entresto (heart failure): 53%. ... Today this would amount to about $3,400 for a 30-day supply. After the negotiated price takes effect ...